Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
301 | 3632 | 26.8 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1085 | 9394 | RADICAL HYSTERECTOMY//CERVICAL CANCER//VULVAR CANCER |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CERVICAL CANCER | Author keyword | 134 | 12% | 29% | 1048 |
2 | CERVIX CANCER | Author keyword | 56 | 36% | 4% | 128 |
3 | LOCALLY ADVANCED CERVICAL CANCER | Author keyword | 56 | 69% | 1% | 48 |
4 | IMAGE GUIDED BRACHYTHERAPY | Author keyword | 44 | 77% | 1% | 30 |
5 | RADICAL HYSTERECTOMY | Author keyword | 41 | 27% | 4% | 134 |
6 | INTRACAVITARY BRACHYTHERAPY | Author keyword | 37 | 58% | 1% | 43 |
7 | CERVICAL CARCINOMA | Author keyword | 35 | 16% | 5% | 199 |
8 | COMPLETION SURGERY | Author keyword | 27 | 83% | 0% | 15 |
9 | ADVANCED CERVICAL CANCER | Author keyword | 24 | 63% | 1% | 24 |
10 | CARCINOMA OF THE CERVIX | Author keyword | 21 | 43% | 1% | 37 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | CERVICAL CANCER | 134 | 12% | 29% | 1048 | Search CERVICAL+CANCER | Search CERVICAL+CANCER |
2 | CERVIX CANCER | 56 | 36% | 4% | 128 | Search CERVIX+CANCER | Search CERVIX+CANCER |
3 | LOCALLY ADVANCED CERVICAL CANCER | 56 | 69% | 1% | 48 | Search LOCALLY+ADVANCED+CERVICAL+CANCER | Search LOCALLY+ADVANCED+CERVICAL+CANCER |
4 | IMAGE GUIDED BRACHYTHERAPY | 44 | 77% | 1% | 30 | Search IMAGE+GUIDED+BRACHYTHERAPY | Search IMAGE+GUIDED+BRACHYTHERAPY |
5 | RADICAL HYSTERECTOMY | 41 | 27% | 4% | 134 | Search RADICAL+HYSTERECTOMY | Search RADICAL+HYSTERECTOMY |
6 | INTRACAVITARY BRACHYTHERAPY | 37 | 58% | 1% | 43 | Search INTRACAVITARY+BRACHYTHERAPY | Search INTRACAVITARY+BRACHYTHERAPY |
7 | CERVICAL CARCINOMA | 35 | 16% | 5% | 199 | Search CERVICAL+CARCINOMA | Search CERVICAL+CARCINOMA |
8 | COMPLETION SURGERY | 27 | 83% | 0% | 15 | Search COMPLETION+SURGERY | Search COMPLETION+SURGERY |
9 | ADVANCED CERVICAL CANCER | 24 | 63% | 1% | 24 | Search ADVANCED+CERVICAL+CANCER | Search ADVANCED+CERVICAL+CANCER |
10 | CARCINOMA OF THE CERVIX | 21 | 43% | 1% | 37 | Search CARCINOMA+OF+THE+CERVIX | Search CARCINOMA+OF+THE+CERVIX |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PELVIC RADIATION | 349 | 68% | 8% | 307 |
2 | UTERINE CERVIX | 217 | 19% | 29% | 1056 |
3 | INTRACAVITARY BRACHYTHERAPY | 189 | 75% | 4% | 137 |
4 | STAGE IB | 180 | 47% | 8% | 281 |
5 | PARAAORTIC LYMPH NODES | 165 | 82% | 3% | 96 |
6 | BULKY STAGE IB | 163 | 86% | 2% | 82 |
7 | VOLUME PARAMETERS | 155 | 83% | 2% | 86 |
8 | RADICAL HYSTERECTOMY | 137 | 30% | 11% | 383 |
9 | RATE INTRACAVITARY BRACHYTHERAPY | 137 | 74% | 3% | 101 |
10 | GYNECOLOGIC ONCOLOGY GROUP | 136 | 17% | 20% | 729 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BRACHYTHERAPY | 12 | 13% | 2% | 83 |
2 | JOURNAL OF CONTEMPORARY BRACHYTHERAPY | 7 | 18% | 1% | 33 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Immunotherapy: An Evolving Paradigm in the Treatment of Advanced Cervical Cancer | 2015 | 4 | 74 | 31% |
A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer | 2014 | 14 | 18 | 72% |
A Systematic Review of Organ Motion and Image-guided Strategies in External Beam Radiotherapy for Cervical Cancer | 2014 | 8 | 47 | 79% |
Cervical cancer | 2003 | 333 | 79 | 48% |
Chemotherapy for advanced and recurrent cervical carcinoma: Results from cooperative group trials | 2013 | 14 | 46 | 80% |
Chemoradiation in the Management of Cervix Cancer: Current Status and Future Directions | 2013 | 8 | 25 | 96% |
Chemotherapy for recurrent cervical cancer | 2008 | 41 | 88 | 90% |
Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: A systematic review and meta-analysis | 2014 | 4 | 20 | 85% |
Cervical Cancer Clinical Practice Guidelines in Oncology | 2013 | 27 | 131 | 31% |
Management of metastatic cervical cancer: Review of the literature | 2007 | 49 | 83 | 87% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GYNECOL ONCOL GRP | 7 | 15% | 1.2% | 44 |
2 | CHRISTIAN DOPPLER MED RADIAT RADIAT ONCOL | 4 | 26% | 0.4% | 14 |
3 | UMR1030 | 3 | 100% | 0.1% | 3 |
4 | STAT DATA | 3 | 10% | 0.8% | 28 |
5 | GUNMA UNIV HEAVY ION MED | 3 | 60% | 0.1% | 3 |
6 | RADIOTHER Y RADIOBIOL | 3 | 11% | 0.7% | 24 |
7 | SERV CURIETHER IE | 3 | 30% | 0.2% | 7 |
8 | DALLAS FDN CHAIR GYNECOL ONCOL | 2 | 67% | 0.1% | 2 |
9 | FRANK C LOVE CANC | 2 | 67% | 0.1% | 2 |
10 | YONSEI SONG DANG CANC | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000159221 | UTERINE NEOPLASMS MR//PET DIAG//UTERINE NEOPLASMS STAGING |
2 | 0.0000138019 | RADICAL HYSTERECTOMY//RADICAL TRACHELECTOMY//TRACHELECTOMY |
3 | 0.0000092496 | CALIFORNIUM 252//NEUTRON BRACHYTHERAPY//NUCL DATA INFORMAT ANAL GRP |
4 | 0.0000087578 | VAGINAL INTRAEPITHELIAL NEOPLASIA//VAGINAL CANCER//VAGINAL CARCINOMA |
5 | 0.0000074646 | VERTEX FIELD//RENAL SCINTIGRAM//STRAHLENTHER IE KLIN |
6 | 0.0000070576 | ATYPICAL GLANDULAR CELLS//ADENOMA MALIGNUM//ADENOCARCINOMA IN SITU |
7 | 0.0000069583 | SQUAMOUS CELL CARCINOMA ANTIGEN//SCC ANTIGEN//SERPINB3 |
8 | 0.0000051904 | CHROMOSOME 3Q26//PAN RAS//HUMAN TELOMERASE GENE |
9 | 0.0000050973 | PELVIC EXENTERATION//RECURRENT RECTAL CANCER//LOCALLY RECURRENT RECTAL CANCER |
10 | 0.0000050624 | RADIATION PROCTITIS//RADIATION ENTERITIS//PROCTOPATHY |